Publications

Michel, L. (2023). Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart. International Journal of Molecular Sciences, 24(9), 7745. https://doi.org/10.3390/ijms24097745 (Original work published 2023)

Calvet-Seral, J., Crespo-Yuste, E., Mathys, V., Rodriguez-Villalobos, H., Ceyssens, P.-J., Martin, A., & Gonzalo-Asensio, J. (2023). Targeted Chromosomal Barcoding Establishes Direct Genotype-Phenotype Associations for Antibiotic Resistance in Mycobacterium abscessus. Microbiology Spectrum, 11(3), e0534422 [1-14]. https://doi.org/10.1128/spectrum.05344-22 (Original work published 2023)

Desvaux, E., Hemon, P., Soret, P., Le Dantec, C., Chatzis, L., Cornec, D., Devauchelle-Pensec, V., Elouej, S., Duguet, F., Laigle, L., Poirier, N., Moingeon, P., Bretin, S., & Pers, J.-O. (2023). High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren’s syndrome. Journal of Autoimmunity, 103147 [1-10]. https://doi.org/10.1016/j.jaut.2023.103147 (Original work published 2023)

Zaryouh, H., De Pauw, I., Baysal, H., Melis, J., Van den Bossche, V., Hermans, C., Lau, H. W., Lambrechts, H., Merlin, C., Corbet, C., Peeters, M., Vermorken, J. B., De Waele, J., Lardon, F., & Wouters, A. (2023). Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity. Cancer drug resistance, 6(4), 709-728. https://doi.org/10.20517/cdr.2023.62 (Original work published 2023)

Feron, O., Chang, C.-H., & Végran, F. (2023). Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy. Frontiers in Immunology, 14, 1171274 [1-2]. https://doi.org/10.3389/fimmu.2023.1171274 (Original work published 2023)

Dilly, S., Romero Toledo, M., Solier, S., Feron, O., Dessy, C., & Slama Schwok, A. (2023). Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor. Antioxidants (Basel, Switzerland), 12(2), 440 [1-16]. https://doi.org/10.3390/antiox12020440 (Original work published 2023)

Tariq, M., De Souza, A., Bensellam, M., Chae, H.-Y., Jaffredo, M., Close, A.-F., Deglasse, J.-P., Santos, L. R. B., Buemi, A., Mourad, N., Wojtusciszyn, A., Raoux, M., Gilon, P., Broca, C., & Jonas, J.-C. (2023). Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped. Diabetologia : clinical and experimental diabetes and metabolism, 66(4), 709-723. https://doi.org/10.1007/s00125-022-05842-y (Original work published 2023)

Bonaccorsi Riani, E., Daudré-Vignier, V., Ciccarelli, O., Coubeau, L., Iesari, S., Castanares Zapatero, D., Collienne, C., Annet, L., Danse, E., Balligand, J.-L., Lefebvre, C., Dieu, A., Benoit, L., & Reding, R. (2023). Improving Safety in Living Liver Donation: Lessons From Intraoperative Adverse Events in 438 Donors Undergoing a Left Liver Resection. Transplantation Direct, 9(9), e1531 [1-11]. https://doi.org/10.1097/TXD.0000000000001531 (Original work published 2023)

Balligand, J.-L., Brito, D., Brosteanu, O., Casadei, B., Depoix, C., Edelmann, F., Ferreira, V., Filippatos, G., Gerber, B., Gruson, D., Hasenclever, D., Hellenkamp, K., Ikonomidis, I., Krakowiak, B., Lhommel, R., Mahmod, M., Neubauer, S., Persu, A., Piechnik, S., et al. (2023). Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial. JAMA cardiology, 8(11), 1031-1040. https://doi.org/10.1001/jamacardio.2023.3003 (Original work published 2023)

Kerkhove, L., Geirnaert, F., Rifi, A. L., Law, K. L., Gutiérrez, A., Oudaert, I., Corbet, C., Gevaert, T., Dufait, I., & De Ridder, M. (2023). Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer. Cancers, 15(8), 2363 [1-19]. https://doi.org/10.3390/cancers15082363 (Original work published 2023)

Michel, L., Esfahani, H., Verdoy, R., de Mulder, D., Ambroise, J., Roelants, V., Bouchard Bertrand, Savary, J., Dewulf, J. P., Doumont, T., Bouzin, C., Haufroid, V., Luiken, J. J. F. P., Nabben, M., Singleton, M. L., Bertrand, L., Ruiz, M., Des Rosiers, C., Balligand, J.-L., & et al. (2023). A NRF2/beta3-adrenoreceptor axis drives a sustained antioxidant and metabolic rewiring through the pentose-phosphate pathway to alleviate cardiac stress. Biorxiv, 14(Nov (2023) (2023)). https://doi.org/10.1101/2023.11.10.564735 (Original work published 2023)

Spinella, J.-F., Theret, L., Aubert, L., Audemard, E., Boucher, G., Pfammatter, S., Bonneil, E., Bordeleau, M.-È., Thibault, P., Hébert, J., Roux, P. P., & Sauvageau, G. (2023). SPAT: Surface Protein Annotation Tool. bioRxiv. Accepted/in-press. https://doi.org/10.1101/2023.07.07.547075 (Original work published 2023)

Vandermeersch, D., Sansen, P.-Y., & Pothen, L. (2023). Bad luck comes in threes. European Journal of Internal Medicine, 115, 130-131. https://doi.org/10.1016/j.ejim.2023.04.030 (Original work published 2023)

Tan, Y., Lefevre, M., Pierrard, F., Soetens, M., Shoueiry, M., Yildiz, E., Ibanez, S., Özkan, K., Feron, O., Frédérick, R., & Riant, O. (2023). Tandem Heck/Tsuji-Trost Reaction for Uncaging of Alloc-Protected Amines with Palladium Complexes in Living Cells. Journal of Organometallic Chemistry, 996, 122743 [1-9]. https://doi.org/10.1016/j.jorganchem.2023.122743 (Original work published 2023)

Feron, O., Chang, C.-H., & Végran, F. (2023). Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy. Frontiers in Immunology, 14(()), 1171274. https://doi.org/10.3389/fimmu.2023.1171274 (Original work published 2023)

Yildiz, H., Lepere, C., Zorzi, G., Gheysens, O., Roodhans, F., & Pothen, L. (2023). [18F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort. Diagnostics, 13(14), 2316 [1-13]. https://doi.org/10.3390/diagnostics13142316 (Original work published 2023)

Colson, A., Depoix, C., Lambert, I., Leducq, C., Bedin, M., De Beukelaer, M., Gatto, L., Loriot, A., Peers de Nieuwburgh, M., Bouhna, K., Baldin, P., Hubinont, C., Sonveaux, P., & Debiève, F. (2023). Specific hypoxia-inducible factor-2 (HIF-2α) inhibitor PT2385 mitigates placental dysfunction in vitro and in a rat model of preeclampsia (RUPP). Hypertension, 80(5), 1011-1023. https://doi.org/10.1161/HYPERTENSIONAHA.122.20739 (Original work published 2023)

Neyens, D., Hirsch, T., Abdel Aziz Issa Abdel Hadi, A., Dauguet, N., Vanhaver, C., Bayard, A., Wildmann, C., Luyckx, M., Squifflet, J.-L., D’Hondt, Q., Duhamel, C., Huaux, A., Montiel, V., Dechamps, M., & van der Bruggen, P. (2023). HELIOS-expressing human CD8 T cells exhibit limited effector functions. Frontiers in Immunology, 14, 1308539 [1-15]. https://doi.org/10.3389/fimmu.2023.1308539 (Original work published 2023)

Balligand, J.-L., & Michel, L. (2023). Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases. Expert Review of Clinical Pharmacology, 16(11), 1073-1084. https://doi.org/10.1080/17512433.2023.2193681 (Original work published 2023)